Health
New evidence shows microbe strain can orally treat systemic inflammation in psoriasis – Science Codex
LUGANO, 29 October, 2020 – Disruptive innovations in psoriasis are leading the way at EADV’s 29th Congress, EADV Virtual. New data published today shows the first clinical evidence of modulating systemic inflammation by oral delivery of a non-living single strain commensal microbe. This new therapeutic class brings hope for a completely new way of treating this debilitating skin condition (1).
The phase 1b clinical study, by Evelo Biosciences, evaluated EDP1815, a preparation of a non-living single…
-
General18 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General20 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Business22 hours agoWhat $10,000 invested in the iShares S&P 500 IVV ETF could be in 10 years
-
Business23 hours agoHow to make a $1,000 monthly passive income from the share market